{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:04:50Z","timestamp":1793783090035,"version":"4.6.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Asia"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jacasi.2025.02.017","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T14:08:01Z","timestamp":1745935681000},"page":"701-717","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Drug-Coated Balloons-Based Intervention for Coronary Artery Disease"],"prefix":"10.1016","volume":"5","author":[{"given":"Ae-Young","family":"Her","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan Azman Wan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liew Houng","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ong Tiong","family":"Kiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin Ariff","family":"Nuruddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Chang","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ho Hee","family":"Hwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaiful Azmi","family":"Yahaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ChunGuang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosli Mohd","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-6968","authenticated-orcid":false,"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacasi.2025.02.017_bib1","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1161\/CIRCULATIONAHA.118.038065","article-title":"Ten-year clinical outcomes from a trial of three limus-eluting stents with different polymer coatings in patients with coronary artery disease","volume":"139","author":"Kufner","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.02.017_bib2","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jacc.2020.05.026","article-title":"10-year outcomes from a randomized trial of polymer-free versus durable polymer drug-eluting coronary stents","volume":"76","author":"Kufner","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.4244\/EIJ-D-20-00361","article-title":"Impact of coronary lesion complexity in percutaneous coronary intervention: one-year outcomes from the large, multicentre e-Ultimaster registry","volume":"16","author":"Mohamed","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.02.017_bib4","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.4244\/EIJ-D-19-00296","article-title":"Clinical outcomes of long stenting in the drug-eluting stent era: patient-level pooled analysis from the GRAND-DES registry","volume":"16","author":"Kong","year":"2021","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.02.017_bib5","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1161\/01.CIR.0000138929.71660.E0","article-title":"Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis","volume":"110","author":"Scheller","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.02.017_bib6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.5603\/CJ.a2019.0093","article-title":"Drug-coated balloon treatment in coronary artery disease: recommendations from an Asia-Pacific Consensus Group","volume":"28","author":"Her","year":"2021","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib7","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.jcin.2020.02.043","article-title":"Drug-coated balloons for coronary artery disease: third report of the International DCB Consensus Group","volume":"13","author":"Jeger","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jconrel.2016.07.041","article-title":"Local arterial wall drug delivery using balloon catheter system","volume":"238","author":"Tesfamariam","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.jacasi.2025.02.017_bib9","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MCA.0000000000001006","article-title":"Drug-coated balloon treatment for nonsmall de-novo coronary artery disease: angiographic and clinical outcomes","volume":"32","author":"Her","year":"2021","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacasi.2025.02.017_bib10","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3349\/ymj.2020.61.12.1004","article-title":"Impact of dissection after drug-coated balloon treatment of de novo coronary lesions: angiographic and clinical outcomes","volume":"61","author":"Hui","year":"2020","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147057","article-title":"Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: serial IVUS-VH and FFR study","volume":"11","author":"Ann","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.jacasi.2025.02.017_bib12","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.recesp.2016.03.028","article-title":"Serial morphological and functional assessment of the paclitaxel-coated balloon for de novo lesions","volume":"69","author":"Ann","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/j.jacasi.2025.02.017_bib13","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jcin.2022.01.012","article-title":"Treatment of coronary de novo lesions by a sirolimus- or paclitaxel-coated balloon","volume":"15","author":"Ahmad","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib15","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/S0140-6736(20)32173-5","article-title":"Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial","volume":"396","author":"Jeger","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.02.017_bib16","doi-asserted-by":"crossref","first-page":"444","DOI":"10.4070\/kcj.2021.0261","article-title":"Clinical results of drug-coated balloon treatment in a large-scale multicenter Korean registry study","volume":"52","author":"Lee","year":"2022","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/bmj.312.7042.1330","article-title":"Comparison of case fatality in south Asian and white patients after acute myocardial infarction: observational study","volume":"312","author":"Wilkinson","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.jacasi.2025.02.017_bib18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ejcts.2006.01.008","article-title":"Coronary artery size and disease in UK South Asian and Caucasian men","volume":"29","author":"Zindrou","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jacasi.2025.02.017_bib19","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2337\/dc15-1536","article-title":"Diabetes in Asia and the Pacific: implications for the global epidemic","volume":"39","author":"Nanditha","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jacasi.2025.02.017_bib20","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/S0735-1097(98)00444-6","article-title":"Angiographic and clinical outcome following coronary stenting of small vessels: a comparison with coronary stenting of large vessels","volume":"32","author":"Akiyama","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib21","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.jcin.2016.03.025","article-title":"Percutaneous coronary interventions for the treatment of stenoses in small coronary arteries: a network meta-analysis","volume":"9","author":"Siontis","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib22","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1055\/s-0038-1676545","article-title":"Racial differences in ischaemia\/bleeding risk trade-off during anti-platelet therapy: individual patient level landmark meta-analysis from seven RCTs","volume":"119","author":"Kang","year":"2019","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jacasi.2025.02.017_bib23","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.CIR.77.2.372","article-title":"Angiographic and clinical predictors of acute closure after native vessel coronary angioplasty","volume":"77","author":"Ellis","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.jacasi.2025.02.017_bib24","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0735-1097(99)00395-2","article-title":"Short- and long-term evolution of unstented nonocclusive coronary dissection after coronary angioplasty","volume":"34","author":"Cappelletti","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib25","doi-asserted-by":"crossref","first-page":"6254","DOI":"10.3390\/jcm12196254","article-title":"Impact of scoring balloon angioplasty on lesion preparation for DCB treatment of coronary lesions","volume":"12","author":"Shin","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib26","first-page":"11","article-title":"Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: one-year outcomes and optical coherence tomography assessment","volume":"102","author":"Mitsui","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib27","first-page":"E614","article-title":"Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA\/DCB registry)","volume":"97","author":"Kitani","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib28","first-page":"193","article-title":"Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"88","author":"Shin","year":"2016","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib29","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10554-019-01707-5","article-title":"Instantaneous wave-free ratio-guided paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"36","author":"Chung","year":"2020","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2025.02.017_bib30","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcin.2024.04.014","article-title":"Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE \u2162 trial","volume":"17","author":"Gao","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib31","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/j.jcin.2015.08.029","article-title":"Effect of drug-coated balloons in native coronary artery disease left with a dissection","volume":"8","author":"Cortese","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib32","doi-asserted-by":"crossref","first-page":"602","DOI":"10.4244\/EIJ-D-23-00849","article-title":"Predictors of late lumen enlargement after drug-coated balloon angioplasty for de novo coronary lesions","volume":"20","author":"Yamamoto","year":"2024","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.02.017_bib33","doi-asserted-by":"crossref","first-page":"191","DOI":"10.4070\/kcj.2022.0297","article-title":"Vascular remodeling after drug-coated balloon treatment: insight from optical coherence tomography","volume":"53","author":"Shin","year":"2023","journal-title":"Korean Circ J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib34","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jjcc.2022.07.007","article-title":"Post-procedural quantitative flow ratio gradient and target lesion revascularization after drug-coated balloon or plain-old balloon angioplasty","volume":"80","author":"Kirigaya","year":"2022","journal-title":"J Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib35","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.jcin.2024.04.014","article-title":"Intravascular ultrasound vs angiography-guided drug-coated balloon angioplasty: the ULTIMATE \u2162 Trial","volume":"17","author":"Gao","year":"2024","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.carrev.2024.04.001","article-title":"Editorial: Is the axiom of balloon angioplasty, \"the more you gain the more you lose\", still true in the era of DCB with paclitaxel?","volume":"69","author":"Serruys","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib37","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1016\/j.jcin.2023.09.026","article-title":"A prospective randomized trial comparing sirolimus-coated balloon with paclitaxel-coated balloon in de novo small vessels","volume":"16","author":"Ninomiya","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1253\/circj.CJ-17-0095","article-title":"Predictors of recurrent in-stent restenosis after paclitaxel-coated balloon angioplasty","volume":"81","author":"Koiwaya","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jcin.2013.01.132","article-title":"Edge vascular response after percutaneous coronary intervention: an intracoronary ultrasound and optical coherence tomography appraisal: from radioactive platforms to first- and second-generation drug-eluting stents and bioresorbable scaffolds","volume":"6","author":"Gogas","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib40","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.carrev.2020.10.004","article-title":"A prospective multicenter randomized trial to assess the effectiveness of the MagicTouch sirolimus-coated balloon in small vessels: rationale and design of the TRANSFORM I Trial","volume":"25","author":"Ono","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib41","first-page":"E43","article-title":"Procedural optimization of drug-coated balloons in the treatment of coronary artery disease","volume":"98","author":"Lee","year":"2021","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib42","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.jcin.2018.02.002","article-title":"Impact of optimized procedure-related factors in drug-eluting balloon angioplasty for treatment of in-stent restenosis","volume":"11","author":"Rhee","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib43","article-title":"Angiographic and clinical impact of balloon inflation time in percutaneous coronary interventions with sirolimus-coated balloon: a subanalysis of the EASTBOURNE study","author":"Gurgoglione","year":"2024","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib44","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jcin.2022.10.049","article-title":"Clinical Impact of Drug-Coated Balloon-Based Percutaneous Coronary Intervention in Patients With Multivessel Coronary Artery Disease","volume":"16","author":"Shin","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12933-023-01853-0","article-title":"Drug-coated balloon-based versus drug-eluting stent-only revascularization in patients with diabetes and multivessel coronary artery disease","volume":"22","author":"Her","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib46","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(12)61964-3","article-title":"Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial","volume":"381","author":"Byrne","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.02.017_bib47","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jcin.2014.09.023","article-title":"Comparison among drug-eluting balloon, drug-eluting stent, and plain balloon angioplasty for the treatment of in-stent restenosis: a network meta-analysis of 11 randomized, controlled trials","volume":"8","author":"Lee","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib48","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/j.jacc.2013.12.006","volume":"63","author":"Alfonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","article-title":"A prospective randomized trial of drug-eluting balloons versus everolimus-eluting stents in patients with in-stent restenosis of drug-eluting stents: the RIBS IV randomized clinical trial","volume":"66","author":"Alfonso","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib50","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jcin.2017.10.024","article-title":"A randomized comparison of paclitaxel-eluting balloon versus everolimus-eluting stent for the treatment of any in-stent restenosis: the DARE trial","volume":"11","author":"Baan","year":"2018","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib51","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib52","article-title":"Associations between target lesion restenosis and drug-eluting balloon use: an observational study","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacasi.2025.02.017_bib53","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/joic.12327","article-title":"Comparison of clinical results following the use of drug-eluting balloons for a bare-metal stent and drug-eluting stent instent restenosis","volume":"29","author":"Lee","year":"2016","journal-title":"J Interv Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib54","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1093\/eurheartj\/ehz594","article-title":"Paclitaxel-coated balloon angioplasty vs drug-eluting stenting for the treatment of coronary in-stent restenosis: a comprehensive, collaborative, individual patient data meta-analysis of 10 randomized clinical trials (DAEDALUS study)","volume":"41","author":"Giacoppo","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib55","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jcin.2011.07.016","volume":"4","author":"Claessen","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ahj.2016.02.020","article-title":"Small-vessel treatment with contemporary newer-generation drug-eluting coronary stents in all-comers: Insights from 2-year DUTCH PEERS (TWENTE II) randomized trial","volume":"176","author":"van der Heijden","year":"2016","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib57","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.1016\/j.jcin.2020.08.035","article-title":"Drug-coated balloon versus drug-eluting stent for small coronary vessel disease: PICCOLETO II randomized clinical trial","volume":"13","author":"Cortese","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib58","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amjcard.2023.11.043","article-title":"Comparison of clinical outcomes among various percutaneous coronary intervention strategies for small coronary artery disease","volume":"211","author":"Kiyohara","year":"2024","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib59","first-page":"893","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: an all-comers registry study","volume":"93","author":"Uskela","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib60","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s10554-019-01649-y","article-title":"Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions","volume":"35","author":"Chung","year":"2019","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2025.02.017_bib61","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s10554-018-1351-z","article-title":"Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty","volume":"34","author":"Her","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"10.1016\/j.jacasi.2025.02.017_bib62","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1007\/s00380-019-01346-9","article-title":"Plaque modification and stabilization after paclitaxel-coated balloon treatment for de novo coronary lesions","volume":"34","author":"Her","year":"2019","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacasi.2025.02.017_bib63","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00392-016-1019-4","article-title":"Fractional flow reserve-guided coronary angioplasty using paclitaxel-coated balloons without stent implantation: feasibility, safety and 6-month results by angiography and optical coherence tomography","volume":"106","author":"Poerner","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.123.013232","article-title":"Drug-coated balloon angioplasty for de novo lesions on the left anterior descending artery","volume":"16","author":"Gitto","year":"2023","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib65","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00059-020-04938-8","article-title":"Drug-coated balloon versus drug-eluting stent for treating de novo coronary lesions in large vessels: a meta-analysis of clinical trials","volume":"46","author":"Lin","year":"2021","journal-title":"Herz"},{"key":"10.1016\/j.jacasi.2025.02.017_bib66","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0140-6736(24)01594-0","article-title":"Drug-coated balloon angioplasty with rescue stenting versus intended stenting for the treatment of patients with de novo coronary artery lesions (REC-CAGEFREE I): an open-label, randomised, non-inferiority trial","volume":"404","author":"Gao","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.02.017_bib67","doi-asserted-by":"crossref","first-page":"26","DOI":"10.4244\/EIJ-D-23-00124","article-title":"The 17th expert consensus document of the European Bifurcation Club - techniques to preserve access to the side branch during stepwise provisional stenting","volume":"19","author":"Pan","year":"2023","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.02.017_bib68","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00392-015-0957-6","article-title":"Drug eluting balloons as stand alone procedure for coronary bifurcational lesions: results of the randomized multicenter PEPCAD-BIF trial","volume":"105","author":"Kleber","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0251986","article-title":"Drug coated balloons for coronary artery bifurcation lesions: A systematic review and focused meta-analysis","volume":"16","author":"Corballis","year":"2021","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jacasi.2025.02.017_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jacc.2024.08.067","article-title":"Drug-coated balloon angioplasty of the side branch during provisional stenting: the multicenter randomized DCB-BIF Trial","volume":"85","author":"Gao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib71","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3349\/ymj.2016.57.3.606","article-title":"Serial morphological changes of side-branch ostium after paclitaxel-coated balloon treatment of de novo coronary lesions of main vessels","volume":"57","author":"Her","year":"2016","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1028007","article-title":"Drug-coated balloon in the treatment of coronary left main true bifurcation lesion: A patient-level propensity-matched analysis","volume":"9","author":"Pan","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib73","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s00380-021-02000-z","article-title":"Impact of directional coronary atherectomy followed by drug-coated balloon strategy to avoid the complex stenting for bifurcation lesions","volume":"37","author":"Okutsu","year":"2022","journal-title":"Heart Vessels"},{"key":"10.1016\/j.jacasi.2025.02.017_bib74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1186\/s40001-024-01877-6","article-title":"Comparison of angiographic change in side-branch ostium after drug-coated balloon vs drug-eluting stent vs medication for the treatment of de novo coronary bifurcation lesions","volume":"29","author":"Her","year":"2024","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.jacasi.2025.02.017_bib75","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCINTERVENTIONS.109.886945","article-title":"Long-term follow-up on a large cohort of \"full-metal jacket\" percutaneous coronary intervention procedures","volume":"2","author":"Sharp","year":"2009","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib76","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.jcin.2017.04.026","article-title":"Full metal jacket with drug-eluting stents for coronary chronic total occlusion","volume":"10","author":"Lee","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib77","first-page":"793","article-title":"Paclitaxel-coated balloon with bare-metal stenting in patients with chronic total occlusions in native coronary arteries","volume":"81","author":"W\u00f6hrle","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib78","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.821380","article-title":"Clinical outcomes of drug-coated balloon treatment after successful revascularization of de novo chronic total occlusions","volume":"9","author":"Jun","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib79","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.3390\/jcm13123381","article-title":"Impact of drug-coated balloon-based revascularization in patients with chronic total occlusions","volume":"13","author":"Shin","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib80","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jcin.2013.07.005","article-title":"The role of drug-eluting balloons alone or in combination with drug-eluting stents in the treatment of de novo diffuse coronary disease","volume":"6","author":"Costopoulos","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.935263","article-title":"Long-term outcomes of drug-coated balloons in patients with diffuse coronary lesions","volume":"9","author":"Yang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib82","first-page":"1034","article-title":"Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients","volume":"38","author":"Palmerini","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib83","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0140-6736(19)31126-2","article-title":"Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial","volume":"394","author":"Rissanen","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.02.017_bib84","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/MCA.0000000000000755","article-title":"Prospective randomized trial of paclitaxel-coated balloon versus bare-metal stent in high bleeding risk patients with de novo coronary artery lesions","volume":"30","author":"Shin","year":"2019","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jacasi.2025.02.017_bib85","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.028413","article-title":"Single-antiplatelet treatment after coronary angioplasty with drug-coated balloon","volume":"12","author":"Cortese","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacasi.2025.02.017_bib86","first-page":"569","article-title":"Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept","volume":"101","author":"R\u00e4s\u00e4nen","year":"2023","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib87","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib88","first-page":"554","article-title":"Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: analysis from the Victorian Cardiac Outcomes Registry","volume":"99","author":"Nogic","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib89","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.carrev.2012.06.001","article-title":"One-year outcome of patients with diabetes mellitus after percutaneous coronary intervention with three different revascularization strategies: results from the Diabetic Argentina Registry (DEAR)","volume":"13","author":"Mieres","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib90","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.jcin.2021.06.025","article-title":"Impact of diabetes on outcome with drug-coated balloons versus drug-eluting stents: the BASKET-SMALL 2 trial","volume":"14","author":"W\u00f6hrle","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib91","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCINTERVENTIONS.114.001360","article-title":"Incidence, predictors, and implications of reinfarction after primary percutaneous coronary intervention in ST-segment-elevation myocardial infarction: the harmonizing outcomes with revascularization and stents in acute myocardial infarction trial","volume":"7","author":"Stone","year":"2014","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib92","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4646","article-title":"Comparison of clinical outcomes after drug-eluting balloon and drug-eluting stent use for in-stent restenosis related acute myocardial infarction: a retrospective study","volume":"6","author":"Fang","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.jacasi.2025.02.017_bib93","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1016\/j.jcin.2019.04.016","article-title":"Paclitaxel-coated balloon angioplasty versus drug-eluting stent in acute myocardial infarction: the REVELATION randomized trial","volume":"12","author":"Vos","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib94","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.4244\/EIJ-D-19-00723","article-title":"Bare metal or drug-eluting stent versus drug-coated balloon in non-ST-elevation myocardial infarction: the randomised PEPCAD NSTEMI trial","volume":"15","author":"Scheller","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jacasi.2025.02.017_bib95","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.3390\/jcm13051481","article-title":"Cardiovascular outcomes after paclitaxel-coated balloon angioplasty versus drug-eluting stent placement for acute coronary syndrome: a systematic review and meta-analysis","volume":"13","author":"Kondo","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib96","doi-asserted-by":"crossref","first-page":"615","DOI":"10.5603\/CJ.a2020.0105","article-title":"Provisional drug-coated balloon treatment guided by physiology on de novo coronary lesion","volume":"28","author":"Shin","year":"2021","journal-title":"Cardiol J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib97","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1056\/NEJM199504133321507","article-title":"Paclitaxel (taxol)","volume":"332","author":"Rowinsky","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib98","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.jcin.2017.06.021","article-title":"The SABRE trial (sirolimus angioplasty balloon for coronary in-stent restenosis): angiographic results and 1-year clinical outcomes","volume":"10","author":"Verheye","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib99","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.122.012305","article-title":"Combined analysis of two parallel randomized trials of sirolimus-coated and paclitaxel-coated balloons in coronary in-stent restenosis lesions","volume":"15","author":"Scheller","year":"2022","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib100","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jacasi.2025.02.017_bib101","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052788","article-title":"Rationale and design for comparison of non-compliant balloon with drug-coating balloon angioplasty for side branch after provisional stenting for patients with true coronary bifurcation lesions: a prospective, multicentre and randomised DCB-BIF trial","volume":"12","author":"Gao","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.jacasi.2025.02.017_bib102","first-page":"544","article-title":"Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: rationale and design of the TRANSFORM II randomized clinical trial","volume":"100","author":"Greco","year":"2022","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jacasi.2025.02.017_bib103","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ahj.2023.01.007","article-title":"Comparing a strategy of sirolimus-eluting balloon treatment to drug-eluting stent implantation in de novo coronary lesions in all-comers: Design and rationale of the SELUTION DeNovo Trial","volume":"258","author":"Spaulding","year":"2023","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacasi.2025.02.017_bib104","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacasi.2025.02.017_bib105","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1056\/NEJMoa1614954","article-title":"Bioresorbable scaffolds versus metallic stents in routine PCI","volume":"376","author":"Wykrzykowska","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacasi.2025.02.017_bib106","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1161\/CIRCULATIONAHA.117.031843","article-title":"Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials","volume":"137","author":"Ali","year":"2018","journal-title":"Circulation"}],"container-title":["JACC: Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772374725001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T12:51:29Z","timestamp":1758199889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772374725001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":106,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2772374725001851"],"URL":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.02.017","relation":{},"ISSN":["2772-3747"],"issn-type":[{"value":"2772-3747","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Drug-Coated Balloons-Based Intervention for Coronary Artery Disease","name":"articletitle","label":"Article Title"},{"value":"JACC: Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacasi.2025.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}